Myopathy, McArdle type

McArdle Disease or McArdle's Disease, also known as Glycogen Storage Disease Type V (GSD V), is a metabolic disorder characterized by a deficiency of the enzyme myophosphorylase. This enzyme is crucial for the breakdown of glycogen to glucose in muscle cells, making McArdle Disease a form of glycogen storage disease. It is named after Dr. Brian McArdle, who first described the condition in 1951.

Symptoms and Signs

Individuals with McArdle Disease typically experience exercise intolerance, manifesting as fatigue, muscle pains, and cramps during the first few minutes of physical activity (known as the "second wind" phenomenon). Other symptoms may include myoglobinuria (the presence of myoglobin in urine, which can lead to kidney damage), muscle weakness, and in some cases, rhabdomyolysis (a severe breakdown of muscle tissue). Symptoms usually appear in childhood or adolescence, but the severity can vary widely among affected individuals.

Diagnosis

Diagnosis of McArdle Disease involves a combination of clinical evaluation, laboratory tests, and genetic testing. The "Ischemic Forearm Test," once commonly used, is now less favored due to its invasiveness and potential complications. Instead, non-invasive methods like electromyography (EMG) and muscle biopsy are preferred. Genetic testing can confirm the diagnosis by identifying mutations in the PYGM gene, which provides instructions for making myophosphorylase.

Treatment

There is no cure for McArdle Disease, but management focuses on symptom relief and preventing complications. Strategies include tailored exercise programs to improve muscle stamina without triggering symptoms, dietary adjustments (such as high-protein or special carbohydrate diets), and in some cases, supplementation with creatine or other nutrients. Avoiding strenuous activity is recommended to prevent rhabdomyolysis and subsequent kidney damage.

Epidemiology

McArdle Disease is a rare condition, with an estimated incidence of 1 in 100,000 to 1 in 140,000 people worldwide. It affects males and females equally and has been identified in individuals of various ethnic backgrounds.

Research Directions

Research on McArdle Disease is ongoing, with studies focusing on understanding the molecular mechanisms of the disease, exploring new treatment strategies, and improving diagnostic methods. Gene therapy and enzyme replacement therapy are areas of interest, though they are still in the experimental stages.

Myopathy, McArdle type Resources
Latest articles Most recent articles Ongoing trials	Wikipedia